What You Should Know: - Medidata, a Dassault Systèmes company, and Boehringer Ingelheim, today announced a five-year renewal of their collaboration in the wider area of electronic data capture. The agreement extends the use of Rave EDC for Boehringer Ingelheim's clinical trials worldwide and includes myMedidata, Medidata’s suite of patient-facing technologies focused on enhancing patient centricity and diversity in decentralized clinical trials (DCTs). - The
Read More
Decentralized Clinical Trials
ObvioHealth & Oracle Collaborate to Seamlessly Integrate Diverse Data Sets Into Decentralized Clinical Trials in APAC
What You Should Know: - Today, ObvioHealth and Oracle have announced a partnership to enable the rapid collection, integration and analysis of this complex data to get breakthrough therapies to market faster and cheaper within the APAC region. This partnership will integrate ObvioGo, ObvioHealth’s next generation decentralized clinical trial (DCT) platform and mobile app, and Oracle Clinical One Cloud Service, facilitating pharma-grade analytics and reporting that can
Read More
Power Launches with $7M to Diversify Clinical Trials
What You Should Know: - Power, a patient-friendly platform designed to improve access to clinical trial studies emerges from stealth with $7M in seed funding. - The round was led by Footwork and CRV, with additional investments from ARTIS Ventures, South Park Commons, and AirAngels to help Power bring the process of discovering and accessing clinical trials into the future. Modernising and Simplifying Accessibility to Clinical Trials Eighty-six percent
Read More
Medable Partners with Withings Health Solutions to Integrate Health Devices in Decentralized Clinical Trials
What You Should Know: - Medable Inc., the leading SaaS platform provider for patient-centered clinical trials, today announced a new partnership with Withings Health Solutions, the business-to-business division of Withings, one of the global leaders in at-home connected health - Withings’ devices will seamlessly connect to Medable’s decentralized clinical trial platform, reducing the burden on sponsors and sites while empowering patients to participate in trials from home.
Read More
Care Access Acquires IBPClin to Expand Decentralized Clinical Trial Capabilities to Latin America
What You Should Know: - Today, Care Access announced the acquisition of IBPClin, a leading clinical trial center in Rio de Janeiro. As a result, Care Access will bring its innovative approach to decentralized clinical research to Latin America. - The acquisition demonstrates progress toward building diverse representation in clinical research and is a strategic first step following Reify Health’s $220 million investment
Read More
ePROs: Better Patient Input for Better Trial Output
During the pandemic, electronic clinical outcomes assessments (eCOAs) gained prominence as sponsors looked for more agile tools to help them capture patient data remotely through decentralized clinical trials (DCTs). From the adoption of virtual models like eCOAs and DCTs, a new opportunity emerged to enhance the patient experience. Decreasing the amount of time spent on on-site appointments helped reduce patient burden. Additionally, sponsors gained real-time insights on how patients interact
Read More
3 Predictions for Post-COVID Clinical Trial Decentralization
Prior to COVID, major technological transformation initiatives were already underway at many clinical trial sites, sponsors, and contract research organizations (CROs.) But the move to decentralized trials accelerated dramatically in 2020 and 2021–and it’s not slowing down. Survey data from WCG Avoca shows that research sites and sponsors expect 89% of clinical trials to qualify as a hybrid, with a mix of decentralized technology and in-person visits. But what will these
Read More
Reify Health Secures $220M to Support Clinical Trial Diversity at $4.8B Valuation
What You Should Know: - Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220M Series D funding round dedicated to improving diversity in clinical research. The investment comes less than a year after its Series C and brings the company's valuation to $4.8B. - The Series C found was co-led by Altimeter Capital and Coatue, joined by Dragoneer Investment Group and existing investors ICONIQ Growth, Adams Street, and Battery
Read More
THREAD Acquires Clinical Trial Recruitment Solution CureClick
What You Should Know: - THREAD, a technology and consulting service provider enabling electronic clinical outcome assessments and decentralized clinical trials has acquired CureClick, which offers the world’s first proprietary crowdsourcing platform designed to accelerate awareness and participation in clinical research. This acquisition follows THREAD’s recent acquisitions of Modus Outcomes and inVibe, positioning THREAD as the industry’s leading
Read More
Labcorp & Medidata to Co-Develop Digital Biomarkers & Expand Decentralized Clinical Trials
What You Should Know: - Medidata, a Dassault Systèmes company, today announced that Labcorp, a leading global life sciences company, has selected Medidata's technology platform to extend their 14-year partnership, the foundation of their initiative to co-develop digital biomarkers and expand the use and functionality of decentralized clinical trials. Labcorp Drug Development has developed its offerings on Medidata technologies, starting with Rave EDC
Read More
